Innovative Metabolics Raises $5.5M Series A Round

Innovative Metabolics Inc., a developer of neuromodulation technology for chronic disease, has raised $5.5 million in Series A funding, investors in the round confirmed to VentureWire.
MORE ON THIS TOPIC